SCHEMBL4490087

SCHEMBL4490087

COC(=O)c1cnn2c(N[C@@H](C)C(C)C)c(C3CCCC3)c(Cl)nc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.47
ALDH1A1 P00352 10/20 0.42
KDM4E B2RXH2 9/20 0.42
HSD17B10 Q99714 7/20 0.42
HPGD P15428 6/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
TSHR P16473 3/20 0.37
GAA P10253 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAPT P10636 3/20 0.35
TP53 P04637 1/20 0.35
PLAT P00750 1/20 0.34
POLB P06746 2/20 0.34
CASP1 P29466 2/20 0.34
MEN1 O00255 1/20 0.34
ESR1 P03372 1/20 0.34
CASP7 P55210 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506359 1.00 HTR2C (0.47) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL13606379 0.91 ALDH1A1 (0.40) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL4499873 0.91 ALDH1A1 (0.40) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL13606374 0.91 ALDH1A1 (0.40) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL13606380 0.89 HTR2C (0.42) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL13606372 0.87 HTR2C (0.45) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL5776597 0.85 HTR2C (0.32) HTR2C
SCHEMBL4490090 0.83 HTR2C (0.45) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL4502692 0.83 HTR2C (0.54) HTR2CALDH1A1KDM4EHSD17B10HPGD
SCHEMBL13606382 0.79 ALDH1A1 (0.35) HTR2CALDH1A1KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
EP-2032559-A1 2-HETEROCYCLOAMINO-4-IMIDAZOLYLPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION AstraZeneca AB (SE) 2009-03-11 EP disclosed
WO-2007138268-A1 2-HETEROCYCLOAMINO-4-IMIDAZOLYLPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION ASTRAZENECA AB (SE) 2007-12-06 WO disclosed
US-20050187224-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187224-A1 Pyrazolopyrimidines P2RX5, P2RX4, P2RX1 HTR2C 993/4885ALDH1A1 535/4885KDM4E 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.